Literature DB >> 15854037

Immunolocalization of low-affinity prostaglandin E receptors, EP and EP, in adult human epidermis.

Raymond L Konger1, Steven D Billings, Angela B Thompson, Akira Morimiya, Jack H Ladenson, Yvonne Landt, Alice P Pentland, Sunil Badve.   

Abstract

Four prostaglandin (PG)E(2) receptors have been described, termed E-series prostaglandin receptors (EP(1)-EP(4)), that can be further subclassified as low-affinity (EP(1) and EP(2)) or high-affinity (EP(3) and EP(4)) receptors. Activation of the low-affinity PGE(2) receptors is likely to be important in mediating the actions of the high levels of PGE(2) found in various pathologic processes. The pattern of expression of these receptors in epidermis, however, is unknown. We therefore examined the immunolocalization of the EP(1) and EP(2) receptors in human epidermis. The EP(1) and EP(2) receptors demonstrated both plasma membrane and perinuclear or nuclear staining within the basal and spinous layers. Within the granular layer, both receptors were expressed in the cytoplasm with a grainy or granular appearance. The major differences were that the EP(2) receptor demonstrated a zone of decreased to absent plasma membrane staining in the superficial spinous layer and only scattered cellular staining within the granular layer. In contrast, the EP(1) receptor was prominently expressed throughout the stratum granulosum and the plasma membrane staining pattern was seen throughout the spinous layer. In cultured primary human keratinocytes, we also verified the presence of functional EP(1) receptor coupled to intracellular calcium mobilization and EP(2) receptor coupled to cAMP production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15854037     DOI: 10.1111/j.0022-202X.2005.23658.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.

Authors:  Inok Surh; Joyce E Rundhaug; Amy Pavone; Carol Mikulec; Erika Abel; Melissa Simper; Susan M Fischer
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

2.  The EP1 subtype of prostaglandin E2 receptor: role in keratinocyte differentiation and expression in non-melanoma skin cancer.

Authors:  R L Konger; S D Billings; N C Prall; T M Katona; S C Dasilva; C R J Kennedy; S Badve; S M Perkins; P T Lacelle
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-07-22       Impact factor: 4.006

Review 3.  Eicosanoids and Keratinocytes in Wound Healing.

Authors:  Raja K Sivamani
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-07-01       Impact factor: 4.730

4.  Prostaglandin E2 regulates melanocyte dendrite formation through activation of PKCzeta.

Authors:  Glynis Scott; Alex Fricke; Anne Fender; Lindy McClelland; Stacey Jacobs
Journal:  Exp Cell Res       Date:  2007-08-16       Impact factor: 3.905

Review 5.  The physiology of membrane transport and endomembrane-based signalling.

Authors:  Michele Sallese; Teodoro Pulvirenti; Alberto Luini
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

6.  Molecular mechanisms of mouse skin tumor promotion.

Authors:  Joyce E Rundhaug; Susan M Fischer
Journal:  Cancers (Basel)       Date:  2010       Impact factor: 6.639

Review 7.  The role of the EP receptors for prostaglandin E2 in skin and skin cancer.

Authors:  J E Rundhaug; M S Simper; I Surh; S M Fischer
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 8.  Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis.

Authors:  Jaya Gandhi; Lohit Khera; Nivedita Gaur; Catherine Paul; Rajeev Kaul
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

Review 9.  Mammalian Epidermis: A Compendium of Lipid Functionality.

Authors:  Matteo Vietri Rudan; Fiona M Watt
Journal:  Front Physiol       Date:  2022-01-12       Impact factor: 4.566

10.  Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.

Authors:  Elena V Tchetina; John A Di Battista; David J Zukor; John Antoniou; A Robin Poole
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.